SCHEMBL17243633

SCHEMBL17243633

O=C(Nc1c(Cl)cncc1Cl)c1nn(-c2cccc([S+]([O-])c3cccnc3)c2)c2ncccc2c1=O

nearest known ligand 0.48

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ PDE4A P27815 6/20 0.48
▸ KCNH2 Q12809 5/20 0.48
▸ PDE4B Q07343 2/20 0.37
▸ PDE4C Q08493 2/20 0.37
▸ PDE4D Q08499 2/20 0.37
▸ MET P08581 2/20 0.34
▸ PKD1 P98161 1/20 0.34
▸ MAP3K14 Q99558 1/20 0.34
▸ RIPK1 Q13546 5/20 0.34
▸ ABCB1 P08183 1/20 0.34
▸ RARG P13631 1/20 0.33
▸ RORC P51449 1/20 0.33
▸ NR3C1 P04150 1/20 0.33
▸ JAK2 O60674 1/20 0.32
▸ CYP3A4 P08684 1/20 0.32
▸ JAK1 P23458 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17243634 0.90 PDE4A (0.45) PDE4AKCNH2PDE4BPDE4CPDE4D
SCHEMBL17243627 0.84 PDE4A (0.49) PDE4AKCNH2PDE4BPDE4CPDE4D
SCHEMBL17243626 0.84 KCNH2 (0.51) PDE4AKCNH2PDE4BPDE4CPDE4D
SCHEMBL17243630 0.84 PDE4A (0.49) PDE4AKCNH2PDE4BPDE4CPDE4D
SCHEMBL17243635 0.83 PDE4A (0.48) PDE4AKCNH2PDE4BPDE4CPDE4D
SCHEMBL17243632 0.83 KCNH2 (0.52) PDE4AKCNH2PDE4BPDE4CPDE4D
SCHEMBL17243914 0.82 PDE4A (0.41) PDE4AKCNH2PDE4BPDE4CPDE4D
SCHEMBL17243629 0.79 PDE4A (0.46) PDE4AKCNH2PDE4BPDE4CPDE4D
SCHEMBL17243636 0.79 PDE4A (0.46) PDE4AKCNH2PDE4BPDE4CPDE4D
SCHEMBL17243631 0.78 PDE4A (0.45) PDE4AKCNH2PDE4BPDE4CPDE4D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9181244-B1 Substituted pyrido[2,3-c]pyridazin-4(1H)-ones as tumor necrosis factor alpha and phosphodiesterase 4 inhibitors Xuanzhu Pharma Co., Ltd. (CN) 2015-11-10 — — US disclosed
US-9181244-B1 Substituted pyrido[2,3-c]pyridazin-4(1H)-ones as tumor necrosis factor alpha and phosphodiesterase 4 inhibitors Xuanzhu Pharma Co., Ltd. (CN) 2015-11-10 — — US disclosed
Send feedback